Cryptococcal pleuritis developing in a patient on regular hemodialysis

K Kinjo1, S Satake, T Ohama

  • 1Department of Internal Medicine, Okinawa Prefectural Hokubu Hospitla, Okinawa, Japan. keikinjo@yahoo.co.jp

Clinical Nephrology
|September 19, 2009
PubMed

Insights

This case highlights a rare instance of cryptococcal pleuritis in a hemodialysis patient who also carried human T lymphotrophic virus Type I (HTLV-I). Physicians should consider this fungal infection in dialysis patients with unexplained pleural effusion.

Area of Science:

  • Infectious Diseases
  • Nephrology
  • Mycology

Background:

  • Patients undergoing regular hemodialysis are immunocompromised and susceptible to various infections.
  • Human T lymphotrophic virus Type I (HTLV-I) carriers have altered immune function, increasing susceptibility to opportunistic infections.
  • Pleural effusion is a common complication in dialysis patients, with diverse potential etiologies.

Observation:

  • A 64-year-old male on hemodialysis and with HTLV-I presented with persistent cough and unilateral pleural effusion.
  • Pleural fluid analysis revealed Cryptococcus neoformans, with positive antigen tests confirming cryptococcal pleuritis.
  • The patient had isolated pleural involvement without evidence of pulmonary parenchymal lesions.

Findings:

  • Cryptococcal pleuritis is an exceptionally rare condition, particularly in patients on dialysis.
  • This case represents one of the few reported instances of cryptococcal pleuritis in a dialysis patient.
  • The absence of pulmonary lesions makes this presentation of cryptococcal pleuritis unusual.

Implications:

  • This case underscores the importance of considering rare fungal infections like cryptococcosis in dialysis patients presenting with unexplained pleural effusion.
  • Early diagnosis and treatment are crucial for managing cryptococcal pleuritis, especially in immunocompromised individuals.
  • Further research into the specific risks and management of fungal pleural infections in dialysis patients is warranted.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...